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Summary
Planar bone scintigraphy is highly sensitive but it may not be sensitive enough
to detect subtle lesions in complex bony structures such as the spine. The
accurate anatomic localisation of lesions in regions such as this is also limited
using planar images. Single Photon Emission Computed Tomography (SPECT)
results in a higher lesion contrast resulting in an improved sensitivity for the
detection of subtle lesions. SPECT also enables improved lesion localisation,
often valuable in distinguishing benign from malignant disease in the spine.
A number of previous studies have demonstrated that the addition of SPECT of
the spine significantly enhances the value of bone scintigraphy for the detection
of bone metastases compared to planar imaging alone. These studies were
however not done in the African context where patients typically present with
more advanced disease.
In a retrospective study of 576 patients with known primary tumors sent to our
institution for bone scintigraphy for the diagnosis of bone metastases, we
evaluated 119 patients in whom both planar imaging and SPECT were
obtained. The studies were graded for the probability of metastatic disease, and
the number of spinal lesions was determined with and without SPECT. The
influence of adding SPECT on the interpretation of the study was determined in
terms of the reported probability of metastatic disease, the exclusion and
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confirmation of metastatic disease, the decisiveness of interpretation, and the
number of spinal lesions.
The addition of SPEeT resulted in a statistically significant change in the
interpretation of studies, although the actual numbers of patients affected were
relatively small. SPEeT resulted in a more decisive interpretation of bone
scintigraphy. There was a significant increase in the number of spinal lesions
detected after the addition of SPEeT.
It was concluded that although the use of SPEeT is ideal, acceptable results
could be achieved using planar imaging alone in this patient population. This is
particularly relevant in the African context, where SPEeT is often unavailable or
scarce and in great demand.
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vOpsomming
Planare beenflikkergrafie is hoogs sensitief, maar moontlik nie sensitief genoeg
om subtiele letsels in ingewikkelde beenstrukture soos die werwelkolom aan te
toon nie. Akkurate anatomiese lokalisasie van letsels in die genoemde strukture
is beperk wanneer slegs planare beelde gebruik word. Enkelfoton-uitstraling
Rekenaartomografie (EFERT) lewer 'n hoër letsel kontras, wat 'n verbeterde
sensitiwiteit vir die opsporing van subtiele letsels tot gevolg het. EFERT lei ook
tot verbeterde letsel lokalisasie, wat dikwels van waarde is om onderskeid
tussen benigne en maligne siekte in die werwelkolom te tref.
Reeds met 'n aantal vorige studies is aangetoon dat die toevoeging van
EFERT van die werwelkolom die waarde van beenflikkergrafie in die opsporing
van beenmetastases beduidend verhoog bo dié van planare beelding alleenlik.
Hierdie studies is egter nie in omstandighede eie aan Afrika gedoen nie, waar
pasiënte kenmerkend met gevorderde siekte voordoen.
In In terugskouende studie van 576 pasiënte met bekende primêre tumore, wat
na ons instelling verwys is vir beenflikkergrafie om beenmetastases op te spoor,
het ons 119 pasiënte, wat beide planare beelding en EFERT ondergaan het,
ge-evalueer. Die studies is gegradeer volgens die waarskynlikheid vir
metastatiese siekte, en die hoeveelheid werwelkolom letsels, met en sonder
EFERT, is bepaal. Die invloed van EFERT op die vertolking van die studie is
bepaal in terme van die waarskynlikheid van metastatiese siekte, die
bevestiging en uitskakeling daarvan, die beslistheid van vertolking, en die
hoeveelheid werwelkolom letsels.
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Die toevoeging van EFERT het tot 'n statisties beduidende verandering in die
vertolking van studies gelei, alhoewel die werklike getal pasiënte wat hierdeur
geraak is, relatief min was. EFERT het 'n meer besliste vertolking van
beenflikkergrafie tot gevolg gehad. Daar was 'n beduidende toename in die
hoeveelheid werwelkolom letsels wat opgespoor is na die toevoeging van
EFERT.
Daar is tot die slotsom gekom dat, alhoewel die gebruik van EFERT wenslik is,
aanvaarbare resultate met slegs die gebruik van planare beelding in hierdie
pasiënt bevolkingsgroep verkry kan word. Dit is veral van belang in Afrika-
omstandighede, waar EFERT dikwels onbeskikbaar of skaars is, en ook in groot
aanvraag is.
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Introduction
Bone scintigraphy is one of the commonest examinations in nuclear medicine
and has been used extensively in the evaluation of oncology patients to detect
bone metastases. By using optimised imaging techniques, it is usually possible
to determine lesion characteristics that are more likely to represent malignancy.
Osseous metastases occur in 80% of patients with metastatic disease [Holger
et a/., 1998]. About 90% of these metastatic deposits are located in regions of
the bones containing red marrow [Jacobson & Fogelman, 1998] and this high
percentage is due to the fact that the majority of metastases that deposit in
bones originate from hematogenous spread, and red marrow has a richer blood
supply than yellow marrow or cortex. The accurate determination of a lesion's
significance requires knowledge of the pathophysiology and other specific
properties of the patient's primary tumour because some tumours metastasise
preferentially to certain regions of the skeleton than others. Scan abnormalities
also need to be interpreted in the light of the patient's history and physical
examination.
Planar bone scintigraphy is very sensitive for the detection of osseous
metastases and it is well known that it can be used to identify skeletal
metastases before they are visible on radiographs [AI-janabi, 1995; Smith et a/.,
1990]. Despite the strengths of planar bone scintigraphy, it may still not be
sensitive enough to detect subtle lesions, especially in complex regions such as
the spine. It has been argued that planar bone scan appearances are frequently
non-specific for the diagnosis of bone metastases, since many benign bony
lesions demonstrate similar tracer uptake patterns. Furthermore, planar images
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2have limited use for accurate anatomical localization in the evaluation of
complex bony structures such as the spine.
Single Photon Emission Computed Tomography (SPECT) results in a higher
lesion-to-background contrast, which results in improved sensitivity for detection
of lesions [Murray, 1994; Podoloff et aI., 1992]. These three-dimensional
images can be displayed as tomographic slices in the transaxial, coronal and
saggital planes, and as a three-dimensional reconstruction using a rotating cine
display. This results in improved lesion localization, which, in turn, implies that
lesions can be interpreted with more specificity [Murray, 1994]. A number of
previous studies have demonstrated that the addition of SPECT of the spine
significantly enhances the value of bone scintigraphy for the detection of bone
metastases in comparison to planar imaging alone [Podoloff et aI., 1992;
Roland et ai., 1995; Yueh et al., 1996].
In most African countries, a large proportion of the population is poor and has
little formal education compared to those in developed countries. Furthermore
there is often little awareness of the early symptoms of cancer, and screening
programmes are often underdeveloped. Consequently, these patients more
frequently present with cancers at advanced stages. At this point in the
progression of the disease, tumour cells have often already metastasised to the
skeleton. Those centers that do have gamma cameras often only have
equipment capable of performing planar scintigraphy, with SPECT being
unavailable. Where a gamma camera capable of performing SPECT is present,
it will typically have a high workload. The author is not aware of the benefit of
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3SPECT having been demonstrated in a study performed in the African context,
where patients often present later, with more advanced disease. The added
value of SPECT for the detection of bone metastases in a population of patients
such as this needs to be demonstrated. This will provide further insight into the
added value of SPEeT in this context, which, in turn, will assist with decision
making that is more cost-effective and therefore allows for improved patient
care in these countries.
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4Literature Review
Pathophysiology of Bone Metastases:
A metastasis is defined as a growth, separate from the primary tumour, which
has arisen from detached, transported fragments of the primary tumour.
Dissemination of malignant cells throughout the body, and their survival to form
secondary growths, constitute a complicated process dependent on both host
and tumour tissue factors [Morgan-Pakes, 1995]. Metastases are the major
cause of treatment failure in cancer patients.
Once tumour cells have become detached from the primary site, their ultimate
destination will depend on the route they travel. These potential pathways
include haematogenous, contiguous spread, through the lymphatic system, and
lastly through cerebrospinal fluid (eSF). However, cancer cells metastasise to
bone almost exclusively by the haematogenous route. Bony metastases
predominantly occur in areas of red marrow, because it is much richer in
vascular endothelium than yellow marrow or the bone cortex. Skeletal
metastases usually develop in the medulla and eventually lead to cortical
damage [Galasko, 1986].
The most frequent tumours to metastasise to bones are carcinomas of the lung,
breast, prostate, kidney and gastrointestinal tract [Johnston, 1970]. Metastatic
neoplasms vastly outnumber primary tumours of the skeleton and generally
affect multiple sites. Autopsy studies have documented skeletal metastases in
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520%-70% of patients with non-osseous primary malignant neoplasms [Hendrix
et a/., 1991]. It is not entirely clear why certain tumour cells are more often found
in bone. However this can be predicted by the behaviour of cancer cells, which
are closely related to the type of the primary tumour itself. The presence of a
large blood supply to the skeleton with the physiologically large vascular spaces
result in relative "blood stagnation" which is a suitable environment for
malignant cells to thrive in bone in general [Krasnowet al., 1997]. Tumour cells,
once metastasised to the skeleton, will start to multiply and invade bony
structures. This invasion and the influence of substances secreted by malignant
cells will normally lead to stimulation of osteoblastic activity in the bone as a
reparative process. Radiologically, the skeletal metastasis of tumour cells from
different tumours can lead to osteolytic, osteosclerotic, or mixed lesions.
Normally, simultaneous production of new bone as well as bone destruction
occurs in both osteolytic and osteosclerotic metastases. In osteolytic lesions the
bone destruction predominates, resulting in the net loss of bone; in
osteosclerotic metastases excessive amounts of new bone formation develop,
with less bone destruction [Galasko, 1986]. Many osteolytic lesions eventually
produce a partial osteosclerotic reaction, often at the periphery of the lesion and
resulting in a mixed pattern.
There are situations, however, in which purely osteolytic lesions occur without
an osteoblastic response. Metastases that usually produce a purely osteolytic
response typically arise from carcinomas of the thyroid, kidney, bladder,
melanoma, multiple myeloma and highly aggressive carcinomas. Bone
formation tends not to occur with these tumours because of two known
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6mechanisms. The first is mediated via the osteoclasts, which are stimulated to
proliferate by the secretion of osteoclast-stimulating factors by the tumour. The
second is through direct bone destruction by the malignant cells, possibly
because of their ability to secrete lytic and other enzymes [Galasko, 1976].
Knowledge of disease pathophysiology and other specific properties of the
patient's primary tumour, along with subsequent correlation of scan
abnormalities to patient history, physical examination, other tests and previous
studies, is essential for determining lesion significance. Knowledge of disease
pathophysiology specifically is very important because this will explain why
some tumours have a greater tendency to spread preferentially to certain
regions in the skeleton than others. For instance, metastases from prostate and
breast carcinoma are more often located in the spine and pelvis because their
malignant cells travel through what is known as Batson's plexus, whereas lung
carcinoma cells move through the main venous channels and so are more often
deposited in the extremities, and metastases are found in a wider variety of
bones [Krasnowet al., 1997].
More than 90% of metastatic bone lesions occur in the axial skeleton and the
spine is the most common site of skeletal metastases (39%) because of its
abundant vasculature and red bone marrow [Taoka et el., 2001]. Therefore the
optimal interpretation of spinal lesions is particularly important in this group of
patients.
Stellenbosch University http://scholar.sun.ac.za
7Bone metastasis is a common complication of several different cancers, and
may be the first indication that the disease has spread beyond the area of the
primary tumour. This normally indicates that the prognosis has worsened.
Management plans of cancer patients also depend on whether a patient does or
does not have bone metastasis. Bone metastasis can lead to various
complications, including fractures, hypercalcemia, and bone pain, and reduced
performance status and quality of life [Serafini, 2001].
Indications for Bone Scintigraphy
The indications for clinician referral of cancer patients for bone scintigraphy to
detect bone metastases are many, most commonly for initial staging of disease
in patients in whom carcinoma was recently diagnosed. This is applicable to
cancers with a greater predilection for early metastasis to bone, such as
prostate, breast, and lung cancers. Some doctors refer the patients for bone
scanning to evaluate the response of bone metastases to therapy and then for
routine follow up after a certain period of time, or to determine the cause of
bone pain reported by the patient in order to manage that pain properly, and
sometimes to reveal the cause of unexplained abnormal values of laboratory
tests.
Radionuclide Bone Scan
Bone scintigraphy is the most frequently performed radionuclide examination,
accounting for 40%-60% of the work in nuclear medicine departments [Holder,
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81990]. Bone scanning is the primary imaging examination used to detect
osseous metastases for a number of primary malignancies.
Radiopharmaceuticals
Condensed phosphate esters or polyphosphate compounds and diphosphonate
compounds labelled with technetium-99m have been used for bone
scintigraphy, with various diphosphonate compounds now used almost
exclusively [Subramanian and McAfee, 1971]. Technetium-99m labelled
methylene diphosphonate (99mTc_MDP)is taken up by chemisorption onto the
phosphorous groups of calcium hydroxyapatite, the basic crystal of bone
[Alazraki, 1996]. The mechanisms of abnormal 99mTc_MDP uptake
demonstrated with bone scanning are complex. The factors known to accelerate
deposition of 99mTc_MDPin bone are increased blood flow to abnormal bone
and increased bone turnover or metabolism resulting in increased osteoblastic
activity, with the latter resulting in an increased surface area of bone crystal
available for binding [Saha, 1992].
Three hours after administration of the activity to a normally hydrated patient,
approximately 35% of the injected dose is excreted by the kidneys, 30%-40% is
associated with bone, 10%-15% is in other tissues, and 5% is in the blood
[Holder, 1990]. Thus metastatic deposits that produce a vigorous osteoblastic
response will be visualized as a "hot spot" on a bone scan [Krishnamurthy et ai.,
1976]. Those lesions that generate a purely osteolytic reaction may not be
detectable unless they are large enough to appear as areas of absent tracer
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9accumulation. Some anablastic tumours, for example, are highly aggressive
and do not allow an osteoblastic response to take place. These can lead to
decreased tracer uptake giving rise to a "cold spot" or a mixed lesion with a
cold centre and a hot periphery [Gold et al., 1990].
Strengths and Weaknesses of Bone Scintigraphy
The bone scan has many major advantages in clinical oncology. It has high
sensitivity for detecting most skeletal metastases and has the capability of
imaging the whole body at relatively low cost and with a low total radiation dose
[Mirza et aI., 2001]. It is also easy to perform on almost every patient, with very
few side effects [Jacobson and Fogelman, 1998]. Bone scanning has a role to
playas a guide in monitoring the response to therapy. Alternative screening
modalities, such as conventional radiography and CT, have been shown to be
less sensitive in the detection of bone marrow metastases than skeletal
scintigraphy [Olson et aI., 1994; Silberstein et ai., 1973]. Scintigraphy may
reveal bone metastases up to 18 months before radiography shows them and
has 50%-80% greater sensitivity [Pagani and Libshitz, 1982].
Bone scanning also has some major disadvantages, and these include the fact
that a bone scan is non-specific for metastatic lesions alone and insensitive, in
particular for purely osteolytic or medullary lesions. In addition, it provides
limited anatomical details if compared to anatomical imaging modalities such as
the CT scan and MRI. With purely intramedullary lesions, i.e. lesions without
cortical involvement, the findings of bone scintigraphy are always negative
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[Thrall and Ellis, 1987]. Small lesions or lesions localized away from the cortex
are therefore likely to be undiagnosed on a bone scan, despite the destruction
of trabecular bone [Taoka et aI., 2001]. Even if most of the bone marrow has
been infiltrated by metastases, but the destroyed medullary bony matrix is
relatively small, the uptake of radiotracers will remain low and therefore may not
be easily appreciated when the uptake is contrasted with that of the normal
cortex [Taoka et aI., 2001]. Furthermore, subtle lesions may be missed on
planar images due to overlying normal bone in complex bony structures such as
the spine.
Interpretation of Planar Bone Scintigraphy
Knowledge of the appearance of a normal scanned image and its variations is
essential to avoid interpretive errors that may lead to a false-positive diagnosis
[Gold et al., 1990]. It is important clinically to recognize that an abnormally
increased localization of tracer represents a similar final common pathway for
all processes that disturb normal rates of osteoblastic activity. Normal structures
or variants that may appear relatively hotter than the rest of the skeleton are:
base of skull, costochondral junctions, external occipital protuberances,
paranasal sinuses, inferior tips of the scapulae, spinous processes of vertebrae,
sternum, sternoclavicular joints, sternomanubrial joints, sacroiliac joints,
unfused epiphyses, [Gold et al., 1990]. There are other structures that appear in
a bone scan, such as thyroid gland due to free pertechnetate in the
Technetium-99m labelled methylene diphosphonate dose; genitourinary system
for the excretion of radioactivity; trauma and inflammation due to the increase in
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the blood supply; any calcified tissue; and, lastly, in injection sites, due to
extravasations of the injected radioactivity.
Features that raise suspicions about skeletal lesions as possible metastases
are asymmetry; extreme variation of intensity; multiple random distribution; and
occurrence being primarily in the axial skeleton [Holder, 1990]. Very
widespread, diffuse metastatic disease can produce a so-called "super scan".
This is an image with extraordinarily high tracer uptake throughout the skeleton,
rather than individual foci. There is increased skeletal accumulation with absent
renal excretion or uptake [Holder, 1990]. At least one third of solitary
abnormalities detected in the bone scans of patients with known malignant
disease result from benign processes or normal variations [Gold et aI., 1990].
When interpreting planar bone scintigraphy, knowledge of disease
pathophysiology and other specific properties of the patient's primary tumour,
along with the subsequent correlation of scan abnormalities to patient history,
physical examination, previous studies, and other radiological examinations, is
crucial for determining the true significance of lesions.
Single Photon Emission Computed Tomography (SPECT)
Frequently, differentiating between benign and malignant lesions in the
vertebral column of cancer patients by using planar imaging alone is very
challenging. Detecting the exact anatomical site of abnormalities of the
vertebrae with planar bone scintigraphy is difficult, and the ability of planar
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imaging to differentiate between malignant and benign vertebral lesions is
therefore limited. SPEeT is more sensitive than planar scintigraphy for
detecting vertebral lesions. Bone imaging with SPEeT can produce increased
image contrast of deeper structures in particular [Holder, 1990].SPEeT imaging
in oncology patients is most useful for the evaluation of the thoracolumbar
spine, skull and pelvis. These areas have extensive surrounding soft tissue
and/or complicated bony structures, and thus the superior image contrast
provided by SPEeT improves lesion detection [Krasnowet a/., 1997].
The increasing availability of SPEeT for routine nuclear medicine studies
reflects the acceptance that this technology improves our ability to detect
abnormalities and to assess their exact location. Because SPEeT minimises
the effects of overlying activity, accurate images of body sections are obtained
for prescribed depths and lesion contrast consequently is improved, which
improves our chances of detecting abnormalities [Delpassand et al., 1995]. An
up to 6-fold increase in image contrast can be obtained with SPEeT imaging
techniques, compared to planar imaging, and visual interpretation of the scans
benefits from this improvement in contrast [Groch and Eawin, 2000]. Subtle
lesions missed when using planar imaging can therefore be detected, resulting
in an increase in sensitivity.
Knowing the exact location of a lesion in the vertebra is crucial to determine its
nature more specifically. SPEeT improves on the specificity of planar imaging
because of improved localization of abnormalities in the vertebrae [Sedonja and
Budihna, 1999]. Sections or slices of the body can be displayed with SPEeT in
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transaxial, coronal, and sagittal views, or as a 3-dimensional image of the
anatomy. This improves the interpreter's ability to locate an abnormality and, on
the basis of its location, to determine whether there is a benign or a malignant
process.
Indications for SPEeT scanning
1. Equivocal Spinal Lesions on Planar Bone Scintigraphy
When multiple areas of increased tracer activity or a super scan consistent with
bony metastases are seen on planar bone scintigraphy, SPEeT examination
usually adds little information to the diagnostic value of the bone scan.
However, the detection of one or a few abnormal vertebrae through bone
scintigraphy is a common finding in clinical practice, particularly in elderly
people who have a high incidence of benign degenerative changes in the
vertebral column [Evan-Sapir et ai., 1993]. The detection of a solitary lesion or a
few lesions in the spine by means of bone scintigraphy poses a diagnostic
dilemma in patients with no other known skeletal metastases. A study
undertaken by Boxer et ai., (1989) found that the spine was the commonest site
for both solitary (52% of cases) and multiple (87%) metastases. The
differentiation between a benign and a malignant vertebral lesion is therefore an
important issue, especially in patients with known cancer. The increased
anatomical information provided by SPEeT can assist with this.
2. Back pain
Vertebral SPEeT should be performed in patients with a known malignancy,
who present with back pain. This may be necessary despite normal planar
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imaging, as back pain is a common presentation of bone metastases in patients
with known primaries, and the overlapping of bony structures may obscure
subtle lesions.
3. Suspicious findings with other imaging studies, e.g. conventional radiography
or CT scan, despite a normal planar bone scintigraphy, specifically in a complex
bony structure such as the spine.
Interpretation of Bone SPEeT
The localization of a lesion to different vertebral parts significantly influences the
likely diagnosis [Han et al., 1998]. This benefit of SPECT was demonstrated in a
study performed by Han et al., (1998). In addition, orthogonal images are easier
to correlate with other cross-sectional anatomical studies (CT and MRI). These
studies can even be co-registered.
Benign lesions are more frequent when increased tracer uptake is seen in the
terminal plate, lateral boundaries of the vertebral body, facet joints, and spinous
process. Malignant lesions are more frequent when scan changes are in the
pedicle; vertebral body with the extension to the pedicle; central parts of the
entire vertebra; and in cold lesions with margins of increased uptake [Evan-
Sapir et al., 1993].
Evan-Sapir et al. (1993) found metastases in 83% of vertebrae with increased
radioactivity in the entire body or part of it with extension to the pedicle,
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whereas Delpassand et a/., (1995) found them in 96%. Sedonja and Budihna
(1999) found only 53.8% of lesions that show abnormal uptake extending from
the body to the pedicle in their study, but the selected population of patients
with predominant osteolytic metastases in their study can explain this somehow
conflicting result of their study with others. Focal uptake in the vertebral body in
the study by Evan-Sapir et al. (1993) represented benign lesions in 96% of
cases. According to Sedonja and Budihna, (1999), these lesions should be
considered as possibly metastatic, especially if situated in the central part of the
vertebral body.
To our knowledge, no work has been done to assess the benefit of SPECT in
the diagnosis of bone metastases in a population of patients with known
malignancies in Africa, where patients often present later and with more
advanced disease. The added value of SPECT for the detection of bone
metastases needs to be confirmed for a population of patients such as this. This
will provide more insight into the added value of SPECT in this context.
Other Modalities for the Diagnosis of Bone Metastases
There are many investigative modalities used for diagnosing bone metastases.
The most important are:
1- Conventional radiography.
2- Computed tomography scan (CT).
3- Magnetic resonance imaging (MRI).
4- Positron Emission Tomography (PET)
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5- Bone biopsy
6- Blood biochemistry
Selection of the appropriate test from all of these modalities depends on many
factors:
1- The sensitivity and specificity.
2- The cost
3- The availability
4- Its usefulness for screening the whole skeleton versus a specific region.
Conventional Radiography
Skeletal conventional radiography is not an accurate tool for the early detection
of bone metastases because it cannot detect lesions until the loss of calcium in
the bone is at least 30-50% [Guzzo et ai., 1969; Gleien et ai., 1976]. This
explains the fact that osteoblastic or osteolytic processes need to be present for
some time before resulting in osteosclerosis or osteolysis that is marked
enough to be detectable. This lack of sensitivity is further compounded by the
fact that the cancellous bone in the medullary canal is usually the first site of
skeletal metastases [Edelstyn et al., 1967].
When conventional radiography is used to examine bony structure, reduced
bone density is mostly detected in cortical bone. Even small intracortical
osteolytic metastases appear in high contrast to the dense compact bone
surrounding them, and they are easily detected with conventional radiographs.
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Thus, conventional radiographs are useful for determining integrity of cortical
bone, and especially for depicting impending or early pathological fractures
[Rubens, 1998].
Conventional radiography is the best modality for characterizing lesions as
osteolytic, osteosclerotic, or mixed lesions and is relatively cheap and widely
available [Gold, 1990]. It is normally reserved for studying limited regions of the
skeleton. Although skeletal surveys can be performed with the use of
conventional radiography, such use results in a relatively high radiation dose
and also increases the cost. Comparison with bone scans reveals that 10 to
40% of skeletal metastases show up as normal in radiographs and as abnormal
in scans, while fewer than 5% of radiographically apparent lesions are shown as
normal when bone scans are used [DeNardo et a/., 1972].
Computed Tomography (CT) Scan
CT scan is much more sensitive than conventional radiography for the depiction
of cortical involvement by metastatic bone disease and provides higher
resolution images with more in-depth anatomical detail [Krasnowet al., 1997].
The contrast resolution of CT is approximately ten times greater than that of
conventional radiography [Gold, 1990].
Both conventional radiography and the CT scan look for a change in bone
density caused by bone destruction due to bony metastases. But a CT scan can
identify bone destruction earlier than conventional radiography; in addition, it
can also assess extra-osseous soft tissue and intra osseous medullary spread
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[Coleman, 1998]. A CT scan is therefore effective in evaluating radiographically
negative areas that are symptomatic and clinically suspicious with regard to
metastases. A CT scan is sensitive with regard to detecting subtle cortical
invasion but it is less sensitive for detecting medullary bone or bone marrow
involvement [Aitchison et al., 1992].
CT scans are usually done for regions of the body such as chest, pelvis or
thoraco-Iumber spine and are relatively more expensive than bone scans and
associated with higher radiation doses to the patients. To do a whole body CT
scan is even more expensive, but a whole body CT scan is not practical
because of the high level of radiation of the patient.
Magnetic Resonance (MR) Imaging
MRI provides images with exceptional anatomical detail, and substantial
information on bone and bone marrow pathology as well as soft tissue and solid
organ disease can be discerned with the use of various pulse sequences and
intravenous contrast materials. It offers the best direct evaluation of bone
marrow [Gold, 1990].
A number of studies have shown MRI to be superior to bone scintigraphy for the
demonstration of spinal metastases [Haulbold-Reuter et al., 1993; Gosfield et
al. 1993; Frank et ai., 1990]. CT is even more sensitive than MR imaging for
the detection of cortical disruption, but MR imaging is more sensitive than CT
for detecting bone marrow involvement [Krasnowet al., 1997]. Nevertheless the
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choice between CT and MR imaging in the diagnosis of bone metastases may
mostly depend on their relative availability [Gold, 1990].
There are several circumstances in which MR imaging may have a significant
impact on the management of the patient with suspected osseous metastatic
bone disease. These include the detection of metastases in symptomatic
patients in whom radiographs and radionuclide bone scans are equivocal or
negative, and the asymptomatic patient with regard to whom there is serious
suspicion of metastatic bone disease, especially when both the radiograph and
the bone scan provide negative results [Jones et ai., 1990].
MR imaging may also be useful for determining the cause of vertebral collapse
in elderly patients with a known primary malignancy. In this case the secondary
osteoblastic reaction detected with bone scanning can be due to a fracture only
or may also be caused by metastases [Yuh et ai., 1989]. In addition, specificity
is higher for MRI because there are fewer abnormalities that will have a similar
appearance to bony metastatic disease [Traill et ai., 1995]. However, one study
utilizing SPECT imaging found similar results to MR imaging [Kosuda et ai.,
1996]. Although whole body MRI techniques are available, they are difficult to
perform, expensive and time-consuming [Krasnowet ai., 1997]. Due to the cost
of MRI machine itself the availability in African countries is doubtful, and even if
found it would be costly and not accessible to huge sector of population
because of poverty.
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Positron Emission Tomography (PET)
PET using 18F-fluoro-deoxyglucose(FOG) images the whole body and can play
a major role not only in the diagnosis but also in the staging, treatment planning
and monitoring of patients with cancer [Wagner et al., 1998]. With FOG PET it is
possible to obtain a whole body image giving a whole body distribution of
glucose metabolism rather than only of the skeleton, and in the absence of
disease, there is virtually no bone visualization. PET has a higher resolution in
comparison to other nuclear medicine methods [Holle et aI., 1996]. It is very
expensive and only available in well-developed countries, and even there it is
not normally available for day-to-day clinical practice. It is not available
anywhere in Africa at present.
FOG PET has been reported to have high sensitivity and specificity (> 90 %) for
the detection of malignant lesions [Martin et aI., 1996]. New imaging techniques
such as MR imaging and Positron Emission Tomography (PET) can identify
bone metastases at an earlier stage of growth than other procedures, before
host reactions of the osteoblasts occur, and both have been reported to provide
a sensitivity approaching 100% for detecting bone metastases [Oaldrup-Link et
aI., 2001].
Bone Biopsy
Bone biopsy provides a rapid, accurate, and relatively safe means of obtaining
proof that a lesion detected by means of conventional radiography, radionuclide
bone scanning, CT, or MR imaging is a metastasis [Gold, 1990]. The decision to
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do a biopsy of a skeletal lesion is usually made after roentgenograms and
appropriate laboratory work have provided a differential diagnosis. At this stage
the method for obtaining the tissue sample is influenced by the location of a
lesion, its surgical accessibility and the strength of presumptive diagnosis. All
the advantages of needle biopsy will be nullified without a close working
relationship between the surgeon and the pathologist [Johnston, 1970]. The
surgeon, in particular, needs to know if he has missed the lesion or whether his
biopsy is adequate. His concern naturally is shared by the radiologist and the
pathologist. Open surgery is utilized only when needle biopsy is diagnostically
inconclusive [Johnston, 1970]. Bone biopsy is an invasive procedure, after all,
and still associated with the risk of complication, especially in the case of
suspected vertebral lesions in the elderly [Aitchison et al., 1992]. Bone biopsy
will not be done routinely for every patient with suspected bone metastases, but
can be of use if there is a solitary bone lesion with high a possibility of being
metastatic.
Blood biochemistry
Markers of bone remodelling could help the clinician in the diagnosis and follow-
up of bone metastases. A common feature of both types of bone metastases
(lytic and sclerotic) is an alternation of bone remodelling activity. The rate of
formation or degradation of the bone matrix can be assessed either by
measuring a prominent enzymatic activity of the bone-forming or -resorbing
cells or by measuring bone matrix components released into the circulation
during formation or resorption [Fontana and Delmas, 2000]. They have been
separated into markers of formation and resorption, but when both events are
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coupled and in balance, either of these markers will reflect the overall rate of
bone turnover. These markers are of unequal specificity and sensitivity, and
some of them have not been fully investigated for bone metastases yet. None of
these markers is disease specific [Fontana and Delmas, 2000]. They are used
mainly for excluding metastatic disease rather than for confirming its presence.
Normal serum values of these markers indicate a very low probability of
metastases. In a study undertaken by Freitas et ai., (1991) it was found that a
Prostate Specific Antigen (PSA) value of s8 ng/ml excluded bone metastases
with a negative predictive value of 98.5%. Others have shown that in prostatic
cancer patients with normal Alkaline Phosphatase and no pain will have a
positive scan in less than 1% of cases [Gerber and Chodak, 1991].
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Aim of the Study
The aim of this research is to investigate the added benefit of performing spinal
SPEeT, compared to planar bone scintigraphy alone, for the diagnosis of bone
metastases in African patients with known primary malignancies.
The objectives:
1. To compare the interpretation of bone scintigraphy for planar imaging alone
with planar imaging with SPEeT with regard to:
a. Overall interpretation of the bone scans
b. Thresholds for considering metastatic disease to be likely, exclusion
of metastatic disease and confirmation of metastatic disease
c. The influence of SPEeT on the decisiveness of interpretation
d. The number of spinal lesions detected.
2. To compare these results with those described in the literature and form an
opinion on the contribution of spinal SPEeT for the detection of metastatic
disease in this group of patients.
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Materials and Methods
Patient Population
Planar and SPEeT studies of bone scans of patients were obtained from
departmental archives. The study was restricted to patients with known primary
malignancies who underwent both planar bone scintigraphy and SPEeT to
diagnose bony metastases in our institution during the year 2000. In our
institution, patients were initially imaged with planar scintigraphy of the entire
skeleton, and SPEeT of the spine was then performed in cases reporting back
pain, equivocal spinal lesions on the planar images, or documented spinal
lesions on previous radiological imaging. In the event of the same patient
undergoing planar bone scintigraphy with SPEeT more than once in the same
year, only the first study was used.
Bone Scanning
Seven hundred and forty MBq (20mei) of technetium-99m methylene
diphosphonate was injected intravenously. Planar imaging was performed three
hours later with a high-resolution low-energy, parallel hole collimator and at
least 500 kilo counts per image were obtained, using Elscint Helix, Elscint SP-4,
Elscint 409 and GE Starcam gamma cameras (GE Medical Systems, USA).
SPEeT imaging was performed immediately after planar imaging, using Elseint
Helix and Elscint SP-4 gamma cameras.
SPEeT data acquisition was performed with the Elseint Helix gamma camera
using a 180-degree oval orbit, step and shoot mode and 3-degree steps
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counted for 20 seconds. For the Elseint SP-4 camera it was performed over 360
degrees with 6-degree steps and counting for 40 seconds per frame. Transaxial,
Coronal and Saggital slices were reconstructed using filtered back-projection
with a Butterworth filter of cut-off frequency of 0.3 and a power factor of 10.
Slice thickness was 4.4 mm. Planar images and SPECT slices were then
recorded onto X-ray film.
Interpretation of scans
Three experienced Nuclear Medicine physicians interpreted the bone scans.
The interpreters had access to clinical information such as the primary
malignancy and any symptoms experienced by the patient. Decisions were
reached by consensus.
Firstly the planar images of the whole skeleton were examined in isolation, with
the interpreters blinded to the SPECT study. A decision was made as to the
likelihood of bony metastasis for the whole skeleton, which was scored on a
four-point scale or graded as 1 = "no metastases" (p < 0.2), 2 = "probably no
metastases" (0.2 < P < 0.5), 3 = "probably metastases" (0.5 < P < 0.8) or 4 =
"metastases" (p > 0.8), with p being equal to the probability of metastatic
disease for the entire skeleton. A decision was also reached as to the number
of spinal lesions present.
Immediately following this, the planar and SPECT images were interpreted
together. Again, a decision was made as to the likelihood of bony metastasis for
the whole skeleton, which was scored using the same four-point scale. A
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decision was again reached as to the number of spinal lesions present, and the
lesions were localized to one or more of the following regions: osteophyte,
vertebral body, pedicle, facet joint, lamina and spinous process. A spinal lesion
was considered metastatic when it involved the pedicle or vertebral body,
whereas lesions not involving these structures were considered to be benign.
Data Analysis
All these data were entered into a spreadsheet for analysis. The results of all
statistical tests were considered significant for P < 0.05.
The grading of the planar imaging alone was then compared with the grading of
the combined planar and SPEeT studies. Attention was given to the effect of
adding SPEeT to the different planar gradings in particular. Scan gradings were
compared using a pairwise nonparametric method (Wilcoxon matched pairs
test) to test for statistical difference between the grading of planar imaging
alone and the grading after addition of SPEeT for all patients, breast cancer
patients and prostate cancer patients.
In order to compare the results, these grades were regrouped into two
categories, using four different classifications. Mosteller's exact test was used to
compare proportions of different groups after each re-classification. However, if
no patients had not undergone upgrading or downgrading as a result of the
addition of SPEeT, Mosteller's exact test was not applicable. In this case
McNemar's test was used, on the condition that a total of at least 10 patients
had undergone upgrading and downgrading.
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The following four classifications were used:
"Metastases" versus "No Metastases"
Firstly, grades of 1 or 2 were considered to indicate the absence of disease
("No Metastases"), while grades of 3 or 4 were considered to indicate the
presence of disease ("Metastases"). The influence that adding SPEeT exerted
on changing the interpretation of the bone scan in such a way that this threshold
was crossed, was then evaluated.
The relative sensitivity, specificity, accuracy, positive predictive value (PPV) and
negative predictive value (NPV) of planar scintigraphy alone with regard to
predicting the result of planar imaging with SPEeT were then calculated for the
all patients in the study. The interpretation of the planar studies alone was
defined as negative for bone metastases for grades of 1 or 2, and positive for
bone metastases for grades of 3 or 4. Similarly, for the interpretation of the
combined planar and SPEeT studies, grades of 1 and 2 were considered to
indicate the absence of disease, while grades of 3 and 4 were considered to
indicate the presence of disease.
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The following formulae were used:
Sensitivity = TP (1)
TP+ FN
Specificity = TN (2)
TN + FP
PPV = TP (3)
TP+ FP
NPV = TN (4)
TN + FN
Accuracy = TN +TP (5)
Total Studies
Where: TP is the number of true positive studies
FP is the number of false positive studies
TN is the number of true negative studies
FN is the number of false negative studies
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"Metastases excluded" versus "Not excluded"
Secondly, grade 1 only was considered to exclude metastases ("Metastases
Excluded"), while grades of 2, 3 and 4 were considered to not exclude
metastases ("Metastases not excluded"). The influence that the addition of
SPECT had on changing the interpretation of the bone scan in such a way that
this threshold was crossed was then evaluated.
The relative sensitivity, specificity, accuracy and positive and negative
predictive values of planar scintigraphy alone, with regard to predicting the
result of planar imaging with SPECT, were then calculated for the all patients in
the study, using formulae (1) to (5). The interpretation of the planar studies
alone was defined as negative for grade 1 only, and positive for grades 2, 3 and
4. Similarly, in interpreting the combined planar and SPECT studies, grade 1
was considered to indicate the absence of disease, while grades 2, 3 and 4
were considered to indicate disease.
"Metastases confirmed" versus "Not confirmed"
Thirdly, grade 4 only was considered to confirm metastases ("Metastases
Confirmed"), while grades of 1, 2 and 3 were considered to not confirm
metastases ("Metastases not confirmed"). The influence that adding SPECT
had on changing the interpretation of the bone scan in such a way that this
threshold was crossed was then evaluated.
The relative sensitivity, specificity, accuracy and positive and negative
predictive values of planar scintigraphy alone, with regard to predicting the
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result of planar imaging with SPEeT, were then calculated for all the patients in
the study, using formulae (1) to (5). The interpretation of the planar studies
alone was defined as positive for grade 4 only, and negative for grades of 1, 2
and 3. Similarly, for the interpretation of the combined planar and SPEeT
studies, grade 4 was considered to indicate disease, while grades 1, 2 and 3
were considered to not indicate disease.
"Decisive" versus "Equivocal"
Grades of 1 and 4 were considered to represent "Decisive" diagnoses, while
grades of 2 and 3 were considered to represent "Equivocal" diagnoses. The
influence that adding SPEeT had on changing the relative numbers of patients
falling into each of these categories was evaluated.
Number of Spinal Lesions
The total number of spinal lesions detected when using planar imaging alone
was compared with the number of spinal lesions detected after the addition of
SPEeT imaging. The number of lesions detected per patient was also
compared for planar imaging alone and after the addition of SPEeT; using the
Wilcoxon matched pairs test.
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Results
Patient Population
A total of 576 patients with known primary malignancies had bone scans
performed by our institution for the diagnosis of bone metastases during 2000.
Of these, 119 patients had planar and SPEeT studies performed. These 119
patients consisted of 45 males and 74 females. Their ages ranged from 11 to 89
years, with a median age of 62 years. In this group of patients, breast
carcinoma and prostate carcinoma were present in the majority of cases. Breast
carcinoma (n = 55) and prostate carcinoma (n = 29) together represented more
than seventy percent of the total number of patients, while other malignancies
were represented in small numbers. A breakdown of the number of patients for
each primary malignancy is given in Table 1. Sixty-four patients (53.8%) were
documented as having symptoms of back pain, and 55 patients (46.2%) had no
documented symptoms of back pain.
Grading of Studies
Grading of the planar whole body scans for the probability of bone metastases
resulted in 57 patients being graded as grade 1 (no metastases), 42 as grade 2
(probably no metastases), 13 as grade 3 (probably metastases) and seven as
grade 4 (metastases). After the addition of SPEeT, 64 patients were graded as
grade 1,21 as grade 2,21 as grade 3 and 13 as grade 4. It can be noted from
these figures that the number of cases in grade 2 ("probably not metastases")
halved with the addition of SPEeT, whereas the number of cases increased
equally in the other three grades. A list of the various patients' primary tumours,
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grading and number of lesions, for both planar imaging and combined planar
and SPEeT imaging is given in Table 2.
A more detailed analysis of the effect on the grading of scans when SPEeT was
added revealed that grading was unchanged in 84 patients (70.6%). A total of
24 patients (20.2%) were "upgraded" (i.e. metastases more likely); 22 of these
were upgraded by 1 grade and two by 2 grades. Of these 24 patients, 16 were
graded as grade 2, four were grade 1 and four were grade 3 when planar
images were used alone. A total of 11 patients (9.2%) were "downgraded" (i.e.
metastases less likely), with nine of them downgraded by 1 grade and two by 2
grades. Of these 11 patients, nine were grade 2 and two were grade 3 when
planar imaging was used alone. It can therefore be noted that the grading of a
total of 35 patients (29.4%) was altered by the addition of SPEeT, while 25 of
these patients were rated as grade 2 ("probably not metastases") when planar
images were used alone.
Of the 57 patients graded as grade 1 by planar imaging alone, only four (7 %)
were re-graded after the addition of SPEeT, and all were upgraded to grade 2.
Of the 42 patients graded as grade 2 by planar imaging alone, 25 (60 %) were
re-graded after the addition of SPEeT. Of the 25, nine were downgraded to
grade 1, 14 were upgraded to grade 3 and two were upgraded to grade 4. Of
the 13 patients graded as grade 3 by planar imaging alone, six (46 %) were re-
graded after the addition of SPEeT. Of these six, two were downgraded to
grade 1 and four were upgraded to grade 4. No change was made in seven
cases graded as grade 4 after the addition of SPEeT (Figure 1).
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When applying a Wilcoxon matched pairs test to all patients and the subgroups
of patients with breast cancer and prostate cancer, no significant difference was
found between the grading obtained by planar imaging alone and that obtained
after the addition of SPEeT. These results are shown in Table 3.
"Metastases" versus "Not Metastases"
This classification was unaffected by the addition of SPEeT in 101 patients
(84.9%). Eighteen patients (15.1 %) were placed in a different group after the
addition of SPEeT. Of these 18 patients, sixteen (13.4%) who were grouped as
not having metastases when using planar imaging alone were regrouped as
having metastases after the addition of SPEeT; all of these patients were
graded as grade 2 ("probably not metastases") when planar imaging was used
alone. The remaining two patients (1.7%) were grouped as having metastases
when planar imaging was used alone and were regrouped as not having
metastases after the addition of SPEeT. Both of these patients were graded as
grade 3 ("probably metastases") when using planar imaging alone.
Mosteller's exact test, which was performed for the all patients, found SPEeT to
make a significant difference (P = 0.0001), as shown in Table 4. In the breast
cancer subgroup (Table 5) and prostate cancer subgroup (Table 6), the
differences were also found be significant (P = 0.0078 & 0.0313 respectively).
Relative to planar imaging and SPEeT, planar imaging alone was found to have
a sensitivity of 53%, a specificity of 98%, an accuracy of 85%, a PPV of 90%,
and a NPV of 84%.
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"Metastases Excluded" versus "Metastases Not Excluded"
In 104 patients (87.4%), this classification was unaffected by the addition of
SPEeT. Fifteen patients (12.6%) were placed in a different group after the
addition of SPEeT. Of these 15 patients, 11 patients (9.2%) were grouped as
not having excluded metastases when using planar imaging alone and they
were regrouped as having excluded metastases after the addition of SPEeT.
Nine of these patients were graded as grade 2 ("probably not metastases")
when using planar imaging alone. Four patients (3.4%) grouped as having
excluded metastases using when planar imaging alone were regrouped as not
having excluded metastases after the addition of SPEeT.
Mosteller's exact test, performed for all patients found SPEeT to make a
significant difference (P = 0.0352) as shown in Table 7. In the breast cancer
subgroup (Table 8) and prostate cancer subgroup (Table 9), the differences
were also found be significant (P = 0.0156 & 0.0313 respectively).
Relative to planar imaging and SPEeT, planar imaging alone was found to have
a sensitivity of 93%, a specificity of 83%, an accuracy of 87%, a PPV of 82%,
and a NPV of 93% for the exclusion of metastasis.
Disease Confirmed versus Not Confirmed
This classification was unaffected by the addition of SPEeT in 113 patients
(95.0%). Six patients (5.0%) who were grouped as not having confirmed
metastases when using planar imaging alone were regrouped as having
confirmed metastases after the addition of SPEeT. Of these patients, four were
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graded as grade 3 ("probably metastases") and two were graded as grade 2
("probably not metastases") when planar imaging alone was used. No patients
grouped as having confirmed metastases using planar imaging alone were
regrouped as having not confirmed metastases after the addition of SPEeT.
It was not valid to apply Mosteller's exact test due to the fact that there were no
patients reclassified from metastases confirmed to metastases not confirmed
after the addition of SPEeT. A McNemar's test was therefore applied to the
group consisting of all patients. The difference was found to be statistically
significant (P = 0.0412), as shown in Table 10. A McNemar's test could not be
used for the breast cancer and prostate cancer subgroups due to the small
number of patients undergoing reclassification.
Relative to using planar imaging and SPEeT, planar imaging alone was found
to have a sensitivity of 54%, a specificity of 100%, an accuracy of 95%, a PPV
of 100%, and a NPV of 95% for the confirmation of metastasis.
Decisive versus Equivocal Diagnosis
In 98 patients (82.4%) this grouping was unaffected by the addition of SPEeT.
Therefore 21 (17.6%) of the total group of patients were reclassified after the
addition of SPEeT. Seventeen patients (14.3%) grouped as equivocal when
using planar imaging alone were regrouped as decisive after the addition of
SPEeT. Eleven of these patients were graded as grade 2 ("probably not
metastases") and six were graded as grade 3 ("probably metastases") when
using planar imaging alone. Four patients (3.4%) were grouped as decisive
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using planar imaging alone and were regrouped as equivocal after the addition
of SPEeT. All of these patients were graded as grade 1 ("no metastases") when
using planar imaging alone.
Mosteller's exact test, performed for all patients, found SPEeT to make a
significant difference (P = 0.0015), as shown in Table 11. In the breast cancer
subgroup (Table 12) and the prostate cancer subgroup (Table 13) the
differences were also found to be significant (P = 0.0020 & 0.0313 respectively).
Number of Lesions
The total number of lesions detected by using planar imaging alone was 137,
while 170 lesions were detected when planar and SPEeT imagings were used.
Therefore the number of lesions detected by planar imaging alone was 19%
less than the number detected using planar imaging with SPEeT. The median
number of lesions per patient was one, with a first quartile of zero (no lesions)
and a third quartile of two lesions for both planar imaging alone and after the
addition of SPEeT.
The number of lesions detected for each patient when using planar imaging
alone and after the addition of SPEeT is shown in Table 2.
Using planar imaging alone, 40 patients had no lesion, 44 patients had one
lesion, 21 patients had two lesions, eight patients had three lesions, four
patients had four lesions, one patient had five lesions and one patient had six
lesions. After the addition of SPEeT, 35 patients had no lesion, 36 patients had
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1 lesion, 22 patients had two lesions, 16 patients had three lesions, eight
patients had four lesions and two patients had five lesions (Figure 2).
The number of detected lesions remained unchanged after adding SPEeT in 66
patients (55.5%). In 37 patients (31.1%), the number of lesions increased,
whereas the number of lesions decreased in 16 patients (13.4%). As mentioned
above, in 40 patients planar imaging detected no lesions but after the addition
of SPEeT lesions were detected in 11 of them, five patients were shown to
have one lesion, three patients had two lesions and three patients had three
lesions.
A Wilcoxon matched pairs test was used to determine the significance of the
difference in the number of lesions detected by planar imaging alone and after
the addition of SPEeT. The difference was found to be statistically significant (P
= 0.00675), as shown in Table 14.
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Table 1: Demographic characteristics of the study population.
Characteristic N (%)
Age [median (Q1,Q3)]1I 62 (50-74)
Gender
Female 74 (62)
Male 45 (38)
Primary Ca
Breast 55 (46.2)
Prostate 29 (24.4)
Gynaecological tumours 10(8.4)
Gastrointestinal tumours 8 (6.7)
Genitourinary tumours 8 (6.7)
Bronchus 3 (2.5)
Lymphoma 3 (2.5)
Melanoma 2 (1.7)
Leukaemia 1(0.8)
Clinical history
Back pain documented
No back pain documented
64 (53.8)
55 (46.2)
1[Q1,Q3 First and third inter-quartile range.
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Table 2: Patients' clinical information, grading and number of lesions: by
Planar imaging alone and after adding SPECT.
No. Age Sex Primary Ca. No. of Grading by No. of Grading by
Lesions Planar Lesions by SPECT
by Planar SPECT
1 81 F Breast 0 2 3 2
2 77 F Breast 1 2 1 2
3 48 F Breast 0 1 0 1
4 49 F Breast 1 2 3 3
5 81 F Breast 2 1 0 1
6 64 F Breast 6 1 4 2
7 47 F Breast 0 1 0 1
8 56 F Breast 1 1 0 1
9 67 F Breast 2 2 0 1
10 46 F Breast 0 1 0 1
11 54 F Breast 0 1 0 1
12 34 F Breast 0 1 0 1
13 59 F Breast 1 4 4 4
14 62 F Breast 2 1 2 1
15 69 F Breast 2 2 1 3
16 55 F Breast 0 1 0 1
17 76 F Breast 1 1 0 1
18 46 F Breast 0 1 0 1
19 48 F Breast 2 2 1 3
20 62 F Breast 1 2 1 1
21 70 F Breast 1 2 1 1
22 89 F Breast 1 2 3 3
23 47 F Breast 0 1 0 1
24 49 F Breast 1 3 3 3
25 35 F Breast 1 4 1 4
26 51 F Breast 0 1 0 1
27 53 F Breast 0 1 0 1
28 55 F Breast 1 2 1 3
29 35 F Breast 1 2 0 1
30 60 F Breast 1 2 1 1
31 41 F Breast 0 1 0 1
32 63 F Breast 0 1 1 1
33 65 F Breast 2 3 1 1
34 70 F Breast 2 3 2 3
35 58 F Breast 1 2 2 2
36 80 F Breast 1 1 2 1
37 86 F Breast 2 1 3 1
38 77 F Breast 3 3 3 4
39 59 F Breast 2 2 1 2
40 82 F Breast 2 2 1 2
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41 62 F Breast 4 2 4 2
42 51 F Breast 2 3 3 3
43 58 F Breast 2 3 4 4
44 56 M Breast 1 2 2 4
45 76 F Breast 2 1 2 1
46 53 F Breast 0 1 0 1
47 51 F Breast 1 1 1 1
48 74 F Breast 2 1 2 1
49 67 F Breast 3 4 3 4
50 75 F Breast 3 4 2 4
51 60 F Breast 0 1 0 1
52 54 F Breast 0 1 0 1
53 60 F Breast 1 3 1 3
54 50 F Breast 1 1 2 1
55 37 F Breast 1 2 2 3
56 71 M Prostate 0 1 0 1
57 65 M Prostate 0 1 2 1
58 60 M Prostate 1 1 1 1
59 69 M Prostate 1 2 1 3
60 75 M Prostate 3 2 4 1
61 67 M Prostate 3 4 4 4
62 82 M Prostate 1 1 1 2
63 73 M Prostate 1 3 1 1
64 75 M Prostate 1 2 1 2
65 74 M Prostate 4 1 2 1
66 69 M Prostate 1 2 2 2
67 69 M Prostate 0 1 0 1
68 72 M Prostate 2 2 3 3
69 68 M Prostate 0 1 1 1
70 76 M Prostate 1 2 2 1
71 74 M Prostate 2 2 5 3
72 70 M Prostate 2 2 2 3
73 74 M Prostate 1 1 1 1
74 75 M Prostate 3 2 3 2
75 64 M Prostate 3 1 3 1
76 82 M Prostate 2 2 3 1
77 74 M Prostate 4 2 4 2
78 80 M Prostate 1 2 2 2
79 75 M Prostate 1 2 1 2
80 73 M Prostate 4 2 0 1
81 76 M Prostate 3 2 4 2
82 75 M Prostate 2 3 1 3
83 64 M Prostate 0 1 3 1
84 80 M Prostate 0 2 1 3
85 38 F Cervix 0 1 1 1
86 23 F Cervix 0 1 0 1
87 59 F Cervix 1 1 1 1
88 47 F Cervix 1 2 1 2
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89 49 F Cervix 1 2 2 2
90 42 F Cervix 1 2 1 3
91 36 F Cervix 0 1 1 2
92 69 F Endometrial 0 3 0 3
93 66 F Ovary 1 3 1 4
94 50 F Bartholine 1 2 1 4
Igland
95 72 F Colon 1 1 2 1
96 18 M Colon 1 2 1 3
97 60 F Colon 0 1 2 1
98 37 M Colorectal 0 1 0 1
99 77 F Stomach 1 1 3 1
100 75 M Stomach 0 1 0 1
101 60 F Oesophagus 0 2 0 2
102 52 M Oesopha__g_us1 4 1 4
103 39 M Bladder 0 1 0 1
104 70 F Bladder 1 1 2 1
105 72 M Bladder 2 2 2 3
106 38 F Renal cell 0 1 0 1
107 18 M Renal cell 1 3 1 4
108 40 M Seminoma 0 1 0 1
109 17 M Testis 0 1 0 1
110 80 F Urethral 5 1 5 2
111 59 F Bronchus 2 4 1 4
112 64 M Bronchus 0 1 0 1
113 50 M Bronchus 1 2 1 2
114 67 M Lymphoma 0 3 2 3
115 54 F Lymphoma 0 1 3 1
116 49 M Lymphoma 1 1 3 1
117 58 F Melanoma 0 1 0 1
118 68 M Melanoma 0 1 0 1
119 11 M Leukaemia 0 1 0 1
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Table 3: Wilcoxon Matched Pairs Test: comparing the grading of planar
imaging alone to the grading after the addition of SPEeT for all cancers,
breast cancer and prostate cancer
Pair of Variables Valid T z P-Ievel
Prostate cancer
N
119
55
29
211.0000 1.703431 0.088488
53.0000 0.775632 0.423690
All cancers
Breast cancer
33.0000 0.00 1.000000
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Table 4: Mosteller's exact test for "metastasis" versus "not metastasis":
All cases as classified by planar imaging alone and after the addition of
SPEeT.
Planaralone
AfterSPEeT Not metastasis Metastasis P-value
Not metastasis 83 2
Metastasis 16 18 0.0001
Table 5: Mosteller's exact test for "metastasis" versus "not metastasis":
Breast cancer cases as classified by planar imaging alone and after the
addition of SPEeT.
Planar alone
AfterSPEeT Not metastasis Metastasis P-value
Not metastasis 37 1
Metastasis 7 10 0.0078
Table 6: Mosteller's exact test for "metastasis" versus "not metastasis":
Prostate cancer cases as classified by planar imaging alone and after the
addition of SPEeT.
Planar alone
AfterSPEeT Not metastasis Metastasis P-value
Not metastasis 21 1
Metastasis 5 2 0.0313
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Table 7: Mosteller's exact test for "metastasis excluded" versus
"metastasis not excluded": All cases as classified by planar imaging
alone and after the addition of SPECT.
Planar alone
AfterSPECT Excluded Notexcluded P-value
Excluded 53 11
Notexcluded 4 51 0.0352
Table 8: Mosteller's exact test for "metastasis excluded" versus
"metastasis not excluded": Breast cancer cases as classified by planar
imaging alone and after the addition of SPECT.
Planar alone
AfterSPECT Excluded Notexcluded P-value
Excluded 25 6
Notexcluded 1 23 0.0156
Table 9: Mosteller's exact test for "metastasis excluded" versus
"metastasis not excluded": Prostate cancer cases as classified by planar
imaging alone and after the addition of SPECT.
Planar alone
AfterSPECT Excluded Notexcluded P-value
Excluded 9 5
Notexcluded 1 14 0.0313
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Table 10: McNemar's test for "metastasis confirmed" versus "metastasis
not confirmed": All cases as classified by planar imaging alone and after
the addition of SPECT.
Planar alone
AfterSPECT Confirmed Not confirmed P-value
Confirmed 7 6
Not confirmed 0 106 0.0412
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Table 11: Mosteller's exact test for "decisive" versus "equivocal": All
cases as classified by planar imaging alone and after the addition of
SPECT.
Planar alone
AfterSPECT Decisive Equivocal P-value
Decisive 60 17
Equivocal 4 38 0.0015
Table 12: Mosteller's exact test for "decisive" versus "equivocal": Breast
cancer cases as classified by planar imaging alone and after the addition
ofSPECT.
Planar alone
AfterSPECT Decisive Equivocal P-value
Decisive 29 9
Equivocal 1 16 0.0020
Table 13: Mosteller's exact test for "decisive" versus "equivocal":
Prostate cancer cases as classified by planar imaging alone and after the
addition of SPECT.
Planar alone
AfterSPECT Decisive Equivocal P-value
Decisive 10 5
Equivocal 1 13 0.0313
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Table 14: Wilcoxon Matched Pairs test for all cancers comparing the
number of lesions detected by planar imaging alone to those detected
after the addition of SPECT.
Pair of Variables Valid T z P-Ievel
N
Number of lesions by Planar 119
alone and lesions by SPECT of
409.5000 2.708946 0.006750
all cancers
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Figure 1: change in planar grading after the addition of
SPEeT
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Figure 2: Number of patients classified according to the
number of lesions detected by planar imaging alone and
after the addition of SPEeT
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Discussion
Bone scintigraphy is one of the commonest examinations in nuclear medicine
and has been used extensively in the evaluation of oncology patients for
detecting bone metastases. No imaging modality is more sensitive in screening
the whole body for skeletal metastases than a bone scan [Delpassand et a/.,
1995]. It can detect many types of lesions, but all of them are not necessarily
malignant. It is sometimes difficult to differentiate between benign and
malignant lesions in the spines of cancer patients, especially in elderly patients
who are more likely to have co-morbid conditions, such as degenerative
disease. It is difficult to detect the exact anatomical site of abnormalities of the
vertebrae using only planar bone scanning. Addition of SPEeT to bone
scanning in the spine improves the ability to detect abnormalities and to assess
their exact anatomical location. Because SPEeT minimizes the activity
superimposed on structures by overlying and underlying structures, accurate
images of body sections are obtained for prescribed depths and lesion contrast
consequently is improved, which improves our chances of detecting subtle
abnormalities. In addition, our ability to locate an abnormality is improved
because sections or slices of the body can be imaged with SPEeT in transaxial,
coronal and sagittal views. On the basis of its location, it is possible to
determine with more certainty whether the observed abnormality is a benign or
malignant process. SPEeT provides better contrast and it localizes the lesions
anatomically better than planar imaging alone. It can detect new lesions not
seen with planar imaging alone because of better contrast, which may result in
upgrading, or it can localize a lesion which was thought to be degenerative on
planar imaging to a pedicle and/or vertebral body, with improved localization
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possibly leading to upgrading. However, improved localization may also lead to
downgrading; a lesion may be thought to be metastatic on planar imaging, for
instance, but SPEeT could localize it to a facet joint consistent with
degenerative disease. Sometimes, there is suspicion of a lesion on planar
imaging, which is not seen with SPEeT. This leads to fewer lesions being
recorded after the addition of SPEeT, due to better contrast, and that, too, may
lead to downgrading. Both upgrading and downgrading may make a significant
alteration to patient management, but this is not necessarily true always,
especially if grading is moved from one equivocal grade to another, for instance
from grade 2 to 3 or vice versa. Even in this situation, the consequent increase
or decrease in the level of suspicion may alter the decided approach to the
problem, with follow up times being altered or extra tests being used.
SPEeT has certain disadvantages, for instance the prolonged imaging time.
This may also lead to patient discomfort, with the potential of motion artifacts.
All these factors will lead to a lower throughput of patients per camera, which
can be a problem, especially if resources are limited. These problems, however,
have been partially solved by the development of multihead gamma cameras,
which greatly reduce the scanning time, thereby improving patient throughput
and easing department workload considerably.
SPEeT is technically more demanding than planar imaging, as it requires
careful quality control and accurate patient set-up. Further, reconstruction and
processing of the images require specialized knowledge [Gates, 1988].
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There were 576 patients with documented primary malignancies who had
planar bone scans for the diagnosis of bone metastasis at our institution during
the year 2000. Of these patients, 119 were examined with both planar imaging
and SPEeT. In accordance with our inclusion criteria, this study was limited to
them. Breast and prostate cancers are among the most common tumours
known to spread to the bone, and these cancers involved more than 70% of our
patients. In the other 457 patients only planar bone scans were performed
because it was considered that there was no need for performing SPEeT, as it
was believed that this would have little impact on the outcome seeing that the
scans were clearly normal or of a metastatic pattern. It is widely accepted that,
for clearly normal or typical metastatic disease, SPEeT adds little to the planar
bone scan. SPEeT was needed as an adjunct for clarification of the planar
bone scan for the 119 patients in our study. This study, in which we compared
the use of planar imaging alone to planar imaging combined with SPEeT was
limited to these 119 "difficult" patients. Based on previous literature, one would
expect SPEeT to contribute significantly in this group [Han et a/., 1998;
Jacobson and Fogelman, 1998].
Despite the absence of a gold standard we approached our data in different
ways in order to compare the results of planar imaging alone to those obtained
after the addition of SPEeT. We started by comparing the overall grading of all
patients by planar imaging alone and the grading after the addition of SPEeT.
Then we regrouped the four grades into two groups, using three different
classifications. These classifications were "metastases/not metastases",
"metastases excluded/not excluded" and "metastases confirmed/not confirmed".
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We made these classifications in an attempt to predict the clinical implication of
adding SPEeT to planar imaging by looking at the effects of adding SPEeT on
proportions of patients in each classification. To determine the capability of
planar imaging alone for predicting the same results as after the addition of
SPEeT, relative sensitivity, specificity, PPV, NPV and accuracy were calculated
in each classification. We examined the overall number and percentage of
patients that were actually affected after the addition of SPEeT for each
classification. We assessed how SPEeT could place significantly more patients
into "decisive" grades, if added to planar imaging.We investigated the impact of
adding SPEeT to the number of lesions detected in these patients.
When we inspected those patients whose grading was altered after the addition
of SPEeT, a total of 35 patients (29.4%) out of the 119 patients were involved.
Twenty-four patients (20.2%) had their grading upgraded after the addition of
SPEeT, compared to 11 patients (9.2%) who were downgraded. This implies
that SPEeT may upgrade more than it downgrades. Of the 24 patients who
were upgraded, 16 (66.7%) initially diagnosed as grade 2, while four (16.7%)
initially were grade 1 and four (16.7%) initially were grade 3. Of the 11
downgraded patients, nine (81.8%) were initially diagnosed as grade 2,
whereas only two (18.2%) were initially grade 3. This data indicates that SPEeT
has the greatest impact for patients with grade 2 scans on planar imaging,
whether it leads to upgrading or downgrading.
Comparing the overall grading using planar imaging alone to grading after the
addition of SPECT, the difference was not statistically significant (P = 0.0884).
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There are many reasons for this discrepancy. First, probably most importantly,
the change of grading occurred in two directions resulting in the upgrading of
one patient cancelling out the downgrading of another and vice versa. Second,
only 35/119 patients were affected and the situation of the majority (31/35)
changed by one grade only. Lastly, the determined P value is close to
significant, i.e. there was an 8% likelihood that this was due to chance.
SPEeT was shown to add little to planar imaging when there is a close to
normal or clearly abnormal planar scan. Our study showed that only 4 (7%) out
of 57 patients who were graded as grade 1 by planar imaging alone were re-
graded after the addition of SPEeT. Interestingly, two of these had documented
back pain while the other two did not have back pain, but had suspicious
vertebral lesions without any other skeletal lesions. There were 53 (93%) out of
57 patients in whom grading was retained as grade 1 even after the addition of
SPEeT. Thirty-one out of 53 did have documented information on back pain. It
is notable that, amongst the grade 1 patients on whom planar imaging was
performed, those who were later upgraded after the addition of SPEeT were no
more likely to have documented back pain than those whose grading remained
unchanged. The prime concern of clinicians regarding cancer patients with back
pain is whether it is caused by metastasis. In a study undertaken by Schutte,
(1979), it was concluded that, in the assessment of malignancies, bone pain is a
good indication for bone scanning, although osteoblastic lesions do not often
present with pain. Bone pain, if metastatic, is attributed to cortical and periosteal
irritation and reactions as seen in lytic processes and fractures [Schutte, 1979].
In breast and prostate cancers one may expect osteoblastic metastases. Back
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pain in cancer patients could be due to any cause other than metastases and
breast and prostate cancer in fact represented more than 70% of our patients.
Previous studies have concluded that SPEeT is indicated to determine the
underlying cause of back pain even if planar imaging is normal [Han et aI.,
1998].
There was no change in the grading of seven patients who were graded as
grade 4 by planar imaging alone after the addition of SPEeT. This is in stark
contrast to the 42 patients who were graded as grade 2 by planar imaging
alone, of whom 25 (60%) were re-graded after the addition of SPEeT, and to
the 13 patients who were graded as grade 3 by planar imaging alone, of whom
seven (46%) were re-graded after the addition of SPEeT, as shown in Figure 1.
Grades 2 and 3 correspond with more equivocal diagnoses, and SPEeT clearly
makes a much greater contribution here than for grades 1 and 4.
The ultimate goal of any investigation report is to be of help to the clinician with
regard to patient management. This partly involves producing a report that is as
decisive as possible. In reality the report has to be stated in terms of
probabilities. Generally speaking, SPEeT will be added to planar imaging to
decrease the uncertainty of certain unclear cases in skeletal scintigraphy. In
other words, the addition of SPEeT increases the diagnostic usefulness of the
study. The nuclear medicine physician will be able to classify many of these
cases as more normal or more abnormal. Using percentage probabilities as
thresholds for our grades, we arranged them into three different classifications,
as metastases versus not metastases (greater than or less than 50%),
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exclusion of disease (less than 20%) and confirmation of metastases (greater
than 80%). These classifications were made in order to predict the impact of a
change in grading on clinical management. To assess the impact of adding
SPEeT to planar grading, we looked at the change in the proportions of patients
in each of these categories before and after the addition of SPEeT in each
classification. This method does not follow individual cases but rather looks at
proportions; therefore there is a risk of significant changes not being detected if
there is equal movement between the groups in both directions. This could
result in statistical tests being negative despite SPEeT having a significant
impact. However, with this data the movement that took place was normally in
both directions but not equal, resulting in all of these tests being significant.
Firstly, to assess movement across a threshold corresponding to a 50%
probability of metastatic disease being present, grades 1 and 2 were classified
as "metastases" and grades 3 and 4 as "not metastases". SPEeT was found to
have a statistically significant impact on this classification, when classifying all
patients, including breast cancer patients and prostate cancer patients (P =
0.0001, 0.0078 and 0.0313 respectively). It can be argued, however, that this
distinction is of limited value in the context of clinical decision-making, and will
have little impact on patient management. However, it is also to be expected
that a patient seen as having about 70% probability of metastatic disease will be
investigated and followed up more closely than a patient with about 30%
probability, even though disease has not been excluded or confirmed in either
case.
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Secondly, to assess a threshold corresponding to a 20% probability of
metastatic disease being present, we classified grade 1 as "metastases
excluded" and all other grades as "metastases not excluded". SPEeT was
found to make a statistically significant impact on this classification, when
classifying all breast cancer patients and prostate cancer patients (P = 0.0352,
0.0156 and 0.0313 respectively). It can be argued that the effective exclusion of
metastatic disease is an indicator of a clinically important difference between
using planar imaging alone and using it with the addition of SPEeT. If
metastasis can be confidently excluded, the patient may, for example, need no
treatment but only follow up. In another patient in whom metastases cannot be
excluded, this may necessitate the need for further investigations and/or more
frequent follow up.
Thirdly, to assess a threshold corresponding to an 80% probability of metastatic
disease being present, grade 4 was classified as "metastases confirmed" and
all the other grades as "metastases not confirmed". This resulted in a
statistically significant difference occurring in this classification of all patients
after the addition of SPEeT (P = 0.0412). A report that confirms the presence of
metastases is also of major clinical benefit to the physician who can then start
treatment, as opposed to going on to perform further investigations and/or
follow up as in the case of metastases not being confirmed.
SPEeT made a statistically significant difference to all three classifications.
According to our knowledge, there is no documented comparison that uses the
same method of analysis as we did. Hence there are no comparable results
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from the literature. Our findings, however, are consistent with the view in the
literature that SPEeT makes a significant contribution in a group of patients
such as those that we have investigated.
As mentioned above, no gold standard was available for this data, and hence
we could not work out the sensitivity, specificity, PPV, NPV and accuracy of
planar imaging with and without SPEeT for comparison. Instead we calculated
values for planar imaging alone, relative to the performance of planar imaging
with SPEeT. These values must not be confused with absolute values and
cannot be compared with absolute values found in the literature. These values
do, however, quantify the performance of planar imaging alone with regard to
the performance after the addition of SPEeT for the diagnosis of bone
metastases. We applied the calculations to the three different classifications
described above.
For the "metastases" versus "not metastases" classification, relative to planar
imaging with SPEeT, planar imaging alone had a sensitivity of 53%, specificity
of 98%, PPV of 90%, NPV of 84%, and an accuracy of 85%. The low sensitivity
means planar imaging alone detected a high number of false negative cases.
This is due to the fact that 16 patients thought to have a probability of metastatic
disease of < 50% on planar imaging alone were considered to have a
probability of> 50% after the addition of SPEeT. It is therefore clear that planar
imaging substantially underestimates the presence of metastatic disease in a
significant proportion of those in whom it is regarded as being present with the
aid of SPEeT. These patients are therefore not likely to receive necessary
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further investigations or adequate close follow up. It must be borne in mind that
the patient population consisted of the 119 "difficult" cases only. This low
sensitivity supports the use of SPECT amongst this group of patients. The high
specificity of the planar imaging alone here means that there were very few
patients classified as false positive. This is due to the fact that only two patients
thought to have a probability of metastatic disease of > 50% on planar imaging
alone were considered to have a probability of < 50% after the addition of
SPECT. Consequently, the use of planar imaging alone would result in
unnecessary investigations or excessively close follow up in a small number of
cases only. The relatively good PPV, NPV and accuracy show that overall for
this population of patients; planar imaging alone classified most patients
similarly before and after the addition of SPECT. Its performance for patients
considered to have a probability of disease of > 50% with the aid of SPECT,
was however poor, with almost half of these being "undergraded" when using
planar imaging alone. It can therefore be concluded that the addition of SPECT
has relatively little impact in cases found to have a probability of metastatic
disease of greater than 50% when using planar imaging. In cases found to have
a probability of less that 50%, the need for performing SPECT is far greater.
For the classification of "metastases excluded" versus "not excluded", planar
imaging alone was found, relative to planar imaging with SPECT, to have a
sensitivity of 83%, specificity of 93%, accuracy of 87%, positive predictive value
of 93% and negative predictive value of 82%. It is clear from this data that
planar imaging alone classifies the majority of patients similarly to when SPECT
is added. In particular, it is effective in predicting those regarded as "not
excluded" with the aid of SPECT. This implies that planar imaging can be used
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alone with a high degree of certainty for the exclusion of metastatic disease.
Using this classification, planar imaging alone does relatively well (sensitivity
and specificity more than 80%) to approach the result of planar imaging
combined with SPEeT. The relatively good PPV, NPV and accuracy show that
overall, for this population of patients, planar imaging alone classified most
patients similarly before and after the addition of SPEeT. Therefore it could be
argued that it is reasonable to not perform SPEeT in cases where metastatic
disease is excluded on the basis of planar imaging alone if resources are
limited. In cases not found to have excluded metastases when using planar
imaging, SPEeT should still be performed, as it has a far greater impact for
these patients.
Lastly, for the classification of patients with "metastases confirmed" versus "not
confirmed" gradings, planar imaging alone was found relative to planar imaging
with SPEeT to have a sensitivity of 54%, specificity of 100%, PPV of 100%,
NPV of 95%, and accuracy of 95%. The low sensitivity demonstrates the fact
that only seven of 13 patients considered to have disease confirmed through
planar imaging combined with SPEeT, were detected when using planar
imaging alone. It is likely that the sensitivity would have been considerably
higher if the patient population had not consisted of the "difficult" 119 cases
only, but rather included all 576 cases. This low sensitivity strongly supports
the use of SPEeT in addition to planar imaging to confirm the presence of
metastasis. The high specificity in this classification was due to the fact that
planar imaging did not classify any patient as a false positive. This again
demonstrates that SPEeT makes little contribution in cases already considered
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to have confirmed disease using planar imaging alone. For many of these
patients planar grading of 4 was based on the presence of metastatic lesions in
the rest of the skeleton. Therefore SPEeT will not make much difference to the
planar classification when the scan is abnormal due to other skeletal lesions
with or without vertebral lesions, and in this case planar imaging will be
sufficient if used alone. However, in these patients, SPEeT may still be of
benefit if used to determine an underlying cause of a back pain, even if there is
no lesion seen in the spine by planar imaging alone. Also SPEeT may be used
if there are lesions in the spine but it is unclear if they are metastatic or not and
also to determine the extent of lesions for planning radiotherapy. Of the seven
patients who were graded as grade 4 by planar imaging alone, four had clear
metastatic lesions outside the spine and the other three had very intense
vertebral lesions. Interestingly, six out the seven had documented back pain,
which might explain the indication for performing SPEeT. The relatively good
PPV, NPV and accuracy show that overall for this population of patients, planar
imaging alone classified most patients similarly before and after the addition of
SPEeT. Therefore cases confirmed as having metastases using planar imaging
benefit little from the addition of SPEeT. In cases where the presence of
metastases is not confirmed, SPEeT makes a contribution and should be
performed if at all possible.
The overall numbers of patients affected
Despite the statistically significant difference in all the three classifications, the
actual numbers of patients involved were small. There were only 18 patients out
of 119 (15%) for whom the final diagnosis changed concerning the
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"metastases/not metastases" classification. As one sees here, this percentage
is small when seen as out of 119 and it gets even smaller (3%) if the entire
number of 576 patients is considered. It was assumed that SPEeT would make
no contribution to planar diagnosis in cases considered as clearly normal or
abnormal. This demonstrates that, although SPEeT has a major impact on
some, it has little impact on the majority of patients. Therefore patients should
be carefully selected for SPEeT scanning, rather than performing SPEeT
routinely on every patient.
Interestingly, when using the "metastases excluded/not excluded" classification,
only 15 patients (12.6% of the 119 undergoing SPEeT) were reclassified and
only four of them were upgraded, which means metastases would have been
incorrectly excluded in a very small number of patients only if only planar bone
scanning were used. Although this may be important for the individuals
concerned, this proportion becomes even smaller if we consider the entire 576
patients, where less than 3% of the total group is affected. This indicates that
SPEeT will not make a contribution in the vast majority of patients when the
scan is used to exclude metastasis and the planar scan is close to normal. It
could therefore be argued that the planar bone scan would be sufficient if used
alone in these circumstances, if this results in improved utilization of limited
resources.
Using the "metastases confirmed/not confirmed" classification, only 6/119 (5%)
patients had their classification changed and all of them were upgraded. This
percentage becomes even smaller (1%) if taken from the total 576 patients.
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This again confirmed that SPECT only makes an impact on a limited population
of patients, so one has to make sure that these patients are carefully selected
for have SPECT rather than perform SPECT routinely on every patient.
Decisive versus Equivocal Results
In this study, 17 patients were reclassified from equivocal results with planar
imaging alone (grades 2 and 3), to decisive results using planar imaging with
SPECT (grades 1 and 4). In comparison, only four patients were reclassified to
equivocal grades after initially being in decisive grades. In this case, a total of
21 (18%) patients had their classification altered after the addition of SPECT.
Comparing the sizes of the decisive and equivocal groups before and after the
addition of SPECT for the whole group of 119 patients, as well as the groups of
patients with breast and prostate carcinoma, there was statistically significant
difference in the performance of planar imaging alone and after the addition of
SPECT (P = 0.0015, 0.0020, and 0.0313 respectively). This implies that the
addition of SPECT leads to more decisive results than planar imaging alone.
This is also consistent with the observation elsewhere in this study where
SPECT is seen as having its main impact on patients graded as 2 or 3 after
planar imaging. The main purpose for adding SPECT to planar imaging is to
attempt to make more precise diagnoses in these unclear cases. If the referring
doctor receives more reports with decisive diagnoses, the clinician's confidence
while making decisions when managing patients is improved.
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Number of lesions detected
SPECT is more sensitive than planar scintigraphy in detecting vertebral lesions.
It is probably also more specific because of its improved localization of
abnormalities in the vertebrae. Consequently, bone SPECT is particularly
valuable in the spine when only one or a few lesions are detected by planar
scintigraphy. When the number of lesions detected through using planar
imaging alone and after the addition of SPECT was compared, the difference
was statistically significant (P = 0.007). In our study, planar bone scanning
detected 137 lesions in the spine compared to 170 lesions detected after the
addition of SPECT. The overall number was therefore 19% lower with planar
imaging alone. This is consistent with a result reported by Gates, (1988) which
reported 17% of lesions detected by SPECT only, and also with a study
undertaken by Han et al., (1998) who reported that 20.1% of the lesions were
not seen on planar imaging.
Interestingly, the number of recorded lesions decreased in some patients after
the addition of SPECT. Therefore not all the lesions seen with planar imaging
were not seen with SPECT. A possible reason for the decrease in the number
of lesions after the addition of SPECT may be that under- or overlying activity is
actually interpreted as spinal lesions when using planar imaging. The
advantage of the better localization with SPECT makes it possible to determine
the exact location of the activity with greater ease. However, lateral and oblique
planar views may to some extent also be able to differentiate between spinal
lesions and other activity. Subtle "lesions" that are suspected with planar
imaging may also not be found using SPECT.
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To some extent the greater the number of spinal lesions the more confident the
physician is that these are due to metastases. This therefore has importance
clinically. The detection of extra lesions also has clinical implications in terms of
patient management using radiotherapy, for example, in which radiation fields
may need to be adjusted following the detection of additional or fewer lesions as
a result of the addition of SPECT.
Our study contains a number of shortcomings. Firstly, and most importantly, the
retrospective nature of our study prevented us from working to a gold standard.
To measure the impact of SPECT in diagnosing bony metastases one ideally
has to have an absolute gold standard such as histo-pathological analysis of
tissue samples removed at surgery, biopsy, or autopsy. But this not possible for
the daily clinical practice. Instead, one can use a combination of other imaging
modalities such as X-rays, CT, MRI, FOG-PET imaging, a follow-up bone scan
and clinical follow-up of the patient. This information was not available for our
study. This made comparison with the results of previous studies from the
literature impossible. Figures of sensitivity, specificity, accuracy, positive and
negative predictive values were calculated for planar imaging relative to the
results of planar imaging and SPECT. If a gold standard had been available, it
would have been possible to calculate the true sensitivities and specificities for
SPECT and planar imaging alone. Receiver Operating Characteristic curves
would then enable comparison between planar imaging alone and planar
imaging with SPECT, and allow the statistical significance of the difference
between them to be calculated.
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Secondly, the system used for grading the studies into four grades was not
based on clear criteria, but rather on the experience of the physicians
concerned, which may have affected the reproducibility of these results in other
hands. This, however, reflects the situation in routine clinical work. It does take
into account the fact that reports are not just positive, or negative, but also have
results that reflect an intermediate probability of disease. An attempt was made
to reflect this using a four-point scale.
Thirdly, retrospective documentation of back pain based on referral forms was
probably unreliable and this should therefore be used with caution in further
analysis. The images were however re-examined prospectively by the same
physicians, which should enhance the consistency of their interpretation.
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Conclusions
1. In this group of patients, the performance of SPEeT was shown to be
significantly different to planar imaging alone in all classifications.
Although there were no comparable results or figures from the literature,
this was consistent with the view expressed in the literature, namely that
SPEeT usually makes a significant contribution in a group of patients
such as those included in this study. Despite the statistically significant
difference, the actual number of patients involved was small, which
demonstrates that although SPEeT can have a major impact on some
patients, this is not the case for the majority. This implies that the
patients who will undergo SPEeT have to be selected as carefully as
possible, rather than performing SPEeT routinely on all patients. In the
vast majority of cancer patients planar imaging alone performs similarly
to cases for which SPEeT is performed for the diagnosis of bony
metastases. This is encouraging, especially as limited resources make
SPEeT unavailable in most African countries.
2. This study also showed that the performance of planar imaging alone for
the exclusion of metastases approached that of SPEeT and hence
planar imaging can be used alone with a high degree of certainty
(relative sensitivity, specificity, PPV, NPV and accuracy all over 80%).
For the confirmation of metastases, however, planar imaging showed
relatively poor sensitivity. When planar imaging shows a metastatic
pattern due to other skeletal lesions with or without vertebral lesions,
SPEeT makes little difference to the planar classification, however,
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SPEeT can still be beneficial if used to determine the underlying cause
of a back pain or for radiotherapy planning.
3. Statistically it has been shown that the addition of SPEeT resulted in a
tendency for interpretation to be more decisive because of clearer
anatomical localization of lesions. This is very important clinically for the
physicians to manage a patient with more certainty of the diagnosis.
4. After the addition of SPEeT, more lesions were detected than those
detected by planar imaging alone and this was statistically significant.
This is clinically relevant because more lesions imply a higher possibility
of malignancy. This increases the certainty and confidence of the nuclear
medicine physician in reporting the scans. It may also have an impact on
individual patient management.
Recommendations
1. This study provides evidence to support the use of SPEeT as adjunct to
planar bone scan imaging for the detection of bone metastases, under
circumstances where SPEeT is available.
2. This study should be followed up by a prospective study using a reliable
gold standard based on bone biopsy, radiological imaging and adequate
clinical follow-up to better evaluate those cases that resulted in a
discrepancy between the interpretation of planar imaging alone and
planar imaging with SPEeT.
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3. An important point to note is that planar imaging is still clinically useful
and that SPECT provides no additional information in a large percentage
of cases. Planar imaging can continue to be used on its own with a great
deal of confidence in countries where no SPECT facilities are present, as
in most African countries.
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